Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy

Not Applicable

Recruiting

• Conditions: Stroke; Pain; Impaired Motor Function

• Registration Number: NCT06842888
• Lead Sponsor: Yale University

Brief Summary

This is a randomized controlled trial which will compare conventional mirror therapy with mirror therapy using the Miraπ device which physically moves a patient's affected limb.

This study will use two parallel groups: (1) receiving conventional mirror therapy as a part of the standard of care as conducted by the participant's clinical care team and (2) receiving mirror therapy with the Miraπ device as conducted by study personnel with the oversight of the participant's clinical care team.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-02-18
• Study First Submitted QC: 2025-02-18
• Study First Posted: 2025-02-24
• Study Start: 2025-03-31
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-13
• Last Update Posted: 2025-05-16
• Primary Completion: 2026-03
• Study Completion: 2026-03

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Participants currently accepted and cleared for rehabilitation in the inpatient rehabilitation unit by the rehabilitation medical director.
• Participants with paralysis or motor function problems of only one hand.
• Participants need mirror therapy because of their health condition.
• Participants' rehabilitation physician determined that mirror therapy would be appropriate for standard of care.
• Participants are able to memorize easy tasks, and able to follow instructions e.g., moving the healthy fingers.

Exclusion Criteria

• Participants who are not cleared physically or medically to participate in standard acute inpatient rehabilitation therapies by the rehabilitation medical director
• Participants who are not able to memorize easy tasks, e.g., moving the healthy fingers.
• Participants with spasticity of the affected hand (as assed by the occupational therapist)
• Minors
• Vulnerable populations

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Jebsen-Taylor Hand Function Test score	At baseline and at discharge (approximately 2-3 weeks after baseline)	Percentage score, which determines how well a participant can do motor tasks for range of motion, strength, and tasks of activities of daily life. Participants have up to 120 seconds to complete tasks. Lower scores indicate less impairment.
McGill Pain Questionnaire (MPQ)	At baseline and at discharge (approximately 2-3 weeks after baseline)	The MPQ is scored by summing the values of words that best describe a person's pain. The score ranges from 0 (no pain) to 78 (severe pain)
Change in Visual Analog Scale (VAS) to assess Pain	At baseline and at discharge (approximately 2-3 weeks after baseline)	The VAS pain scale is a tool for assessing pain intensity. Participants will be asked to mark a point on a 100 mm horizontal line that represents the intensity of their pain. This line has two endpoints: 0: No pain and 100: Worst possible pain imaginable. The distance from the "0" to the mark is measured in millimeters with the resulting number (0-100) being the VAS pain score

Trial Locations

Locations (1)

Rehabilitation and Wellness Center at the Milford Campus of Bridgeport Hospital; 🇺🇸 Milford, Connecticut, United States